Health - Google News: ArQule plunges 23% on drug safety concern - MarketWatch

Health - Google News Google News

ArQule plunges 23% on drug safety concern - MarketWatch Aug 30th 2012, 08:54 Proactive Investors USA & Canada ArQule plunges 23% on drug safety concern MarketWatch BOSTON (MarketWatch) -- Shares of ArQule Inc. (US:arql) plunged 23% to $5.15 on Wednesday on safety concerns about its drug candidate tivantinib for the treatment of lung cancer. In a federal filing made Tuesday, ArQule said that its Japanese ... PropThink: ArQule Setback Increases Risk and Discount Rates for Forward RevenueReuters ArQule plunges on delay in cancer drug studyCBS News ArQule tanks after tox fears force a delay in Asian lung cancer studyFierceBiotech Proactive Investors USA & Canada all 25 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: